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ABSTRACT
RNA:DNA hybrids are transient physiological inter-
mediates that arise during several cellular processes
such as DNA replication. In pathological situations,
they may stably accumulate and pose a threat to
genome integrity. Cellular RNase H activities process
these structures to restore the correct DNA:DNA se-
quence. Yeast cells lacking RNase H are negatively
affected by depletion of deoxyribonucleotide pools
necessary for DNA replication. Here we show that
the translesion synthesis DNA polymerase  (Pol )
plays a role in DNA replication under low deoxyri-
bonucleotides condition triggered by hydroxyurea.
In particular, the catalytic reaction performed by Pol
 is detrimental for RNase H deficient cells, caus-
ing DNA damage checkpoint activation and G2/M ar-
rest. Moreover, a Pol  mutant allele with enhanced
ribonucleotide incorporation further exacerbates the
sensitivity to hydroxyurea of cells lacking RNase H
activities. Our data are compatible with a model in
which Pol  activity facilitates the formation or sta-
bilization of RNA:DNA hybrids at stalled replication
forks. However, in a scenario where RNase H activ-
ity fails to restore DNA, these hybrids become highly
toxic for cells.
INTRODUCTION
The accuracy of genome duplication is mainly guaranteed
by the high fidelity of replicative DNA polymerases that
insert the correct deoxyribonucleotide respecting the base
pairingwith the template. Besides discriminating among the
different bases, replicative polymerases have also to choose
the right sugar moiety (1). In doing so, they are challenged
by the intracellular physiologically high concentration of ri-
bonucleotides (rNTPs), which exceed deoxyribonucleotides
(dNTPs) by over a hundredfold (2). Specific amino acid
residues shape the steric gate in the nucleotide binding site,
driving DNA polymerases to select dNTPs, which lack an
oxygen at the 2′ carbon of the sugar compared to rNTPs (1).
Nonetheless, during DNA replication, a significant num-
ber of ribonucleotides is introduced into the nascent strand
(2). In yeast, at least 1 rNTP is incorporated every 1000
dNTPs, making rNTPs the most frequent non-canonical
nucleotides introduced into the genome (3). Genomic rN-
MPs play an important physiological role in mismatch re-
pair (4–6) but, if not promptly removed from DNA, they
also promote replication stress and genome instability (7–
11).
Chromosome embedded ribonucleotides are usually pro-
cessed by RNase H enzymes, which contribute to the re-
establishment of the correct DNA sequence (3): RNase H1
cleaves RNA:DNA hybrids constituted by at least four con-
secutive ribonucleotides; RNase H2 processes both single
and multiple embedded ribonucleotides (12). Noteworthy,
dysfunction of the RNase H2 complex is a primary cause
of the Aicardi-Goutie`res syndrome, a rare interferonopathy
that mainly affects the brain (13).
Genomic ribonucleotides can also be subjected to muta-
genic processing by Topoisomerase 1, leading to the forma-
tion of short deletions and ultimately double-strand breaks
(14–16). In general, the impaired removal of ribonucleotides
leads to severe consequences, as their persistence in DNA
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distorts the helix structure (17–19) and therefore affects
DNA transactions.
Ribonucleotide incorporation is further increased when
the cellular dNTP pools are reduced, such as following
treatment with the ribonucleotide reductase inhibitor hy-
droxyurea (HU) (8). Indeed, RNase H deficient cells are hy-
persensitive to HU (7–9). During replication, genomic rN-
MPs are not efficiently bypassed by replicative DNA poly-
merases (7,20–22) and cells rely on post-replication repair
mechanisms to overcome these blocks (7). Upon HU treat-
ment, template switching or Pol  -mediated translesion syn-
thesis (TLS) are essential to bypass rNMPs in the DNA
template and to complete genome duplication (7).
Intriguingly, we found that the increased sensitivity to
HU observed in yeast cells lacking RNase H activities
(rnh1Δ rnh201Δ) is almost totally dependent on the TLS
polymerase  (RAD30).
Pol  belongs to the Y-family polymerases and has a
major role in the bypass of several adducts that halt the
progression of replication forks. This versatile polymerase
is known for its excellent ability in bypassing thymidine
adducts and 8-oxo-guanines in an error-free manner (23–
25). In humans, defects in the gene encoding Pol  (POLH)
lead to the onset of the xeroderma pigmentosum variant
(XP-V) genetic syndrome (26), characterized by high inci-
dence of skin cancer and sunlight sensitivity, due to the in-
ability to bypass bulky lesions (27). Besides the TLS func-
tion, human Pol  has been implicated in class switch re-
combination (28,29) and common fragile sites (CFSs) sta-
bility (30–33). Moreover, yeast Pol was reported to be re-
cruited at replication forks upon replication stress induction
(34). Different studies reported that yeast and human Pol 
efficiently utilize rNTPs and extend RNA primers in vitro
(35–37).
In this work, we describe the involvement of Pol  in
genome replication when dNTP pools are low. In particu-
lar, we report that in these conditions Pol catalytic activity
becomes harmful when ribonucleotides cannot be removed.
The enhanced ribonucleotide incorporation, through a Pol
 steric gate mutant (38), further exacerbates this pheno-
type. In the absence of RNase H activities capable of pro-
cessing consecutive ribonucleotides, Pol  activity leads to
the activation of the DNA damage checkpoint and to cell
cycle arrest within a single round of replication in the pres-
ence of low dNTPs. We demonstrate that the toxic activ-
ity of Pol  is not dependent upon ribonucleotides already
present in the template DNA and that RNase H enzymes
are essential to resolve the toxic structures promoted by Pol
. We propose a model where Pol  actively participates
to DNA replication in low dNTPs conditions. Pol  ability
to incorporate rNMPs or extend RNA stretches could be
crucial to enable full-genome duplication during replication
stress at the expense of an accumulation of longer stretches
of consecutive ribonucleotides in the genome. In wild type
cells, thanks to RNase H, this is a tolerable compromise.
However, this activity of Pol  becomes highly toxic when
RNase H enzymes are defective and cells cannot restore the
correct DNA composition and structure.
MATERIALS AND METHODS
Yeast strains, plasmids, media and growth conditions
All the strains used in this work are listed in Supplemen-
tary Table S1 and are derivatives of the W303 RAD5+
background. Strains were generated by standard genetic
procedures. Deletions were obtained by one-step PCR
(39). RNase H2 mutant strains (rnh201-P45D-Y219A and
rnh201-D39A) were obtained by crossing, starting from
MATa sgs1::HIS3 rnh201-D39A and MATa sgs1::HIS3
rnh201-P45D-Y219A (40).
For the indicated experiments, cell cultures were grown
at 28◦C in YEP medium (1% yeast extract, 2% peptone)
containing 2% glucose (YEPD), 2% raffinose (YEPR), or
2% galactose and 2% raffinose (YEPRG). For strains car-
rying plasmids, cells were grown in Synthetic-Complete
(SC) medium supplemented with appropriate sugar(s) and
nutrients to maintain the selection. The concentration of
drugs/chemicals and their addition to the medium are in-
dicated in the figures and their respective legends.
Hydroxyurea was purchased from US Biological (Salem,
MA, USA), Auxin (IAA), Doxycycline (DOXY) andMMS
were purchased from Sigma (Saint Louis, MO, USA).
The pEGUh6-RAD30 (GAL1-6xHIS-RAD30) and
pEGUh6-rad30 D155A D156A (GAL1-6xHIS-rad30-
D155A-E156A) plasmids were kindly provided by T.A.
Kunkel and are described in (41). pFL166.4 (GAL1-6xHIS
-rad30-F35A) was obtained by site-directed mutagenesis
(QuikChange Site-Directed Mutagenesis Kit Thermo
Fisher Scientific, Waltham, Massachusetts USA) on
pEGUh6-RAD30 using oligos 3′-ACA TAG ATA TGA
ATG CCT TTG CTG CAC AGG TTG AGC AGA TGC
G-5′ and 3′-CGC ATC TGC TCA ACC TGT GCA GCA
AAG GCA TTC ATA TCT ATG T-5′, and then verified
by DNA sequencing.
The pFL160.1 plasmid carrying the rnhB-3xminiAID-
HA under TetOFF promoter (42) was prepared as follows.
The rnhB gene was amplified from MG1655 E. coli strain
using primers 3′- TTA ACA TCG ATA GCG GCC GCA
TGA TCGAAT TTG TTT ATC CGCACA CG-5′ and 3′-
GAC TTT TGA CAA GAA ACC ATG GAC GCA AGT
CCC AGTGCG C-5′. The 3X-miniAID sequence was am-
plified from the plasmid BYP7432 (43) using primers 3′-
GCG CAC TGG GAC TTG CGT CCA TGG TTT CTT
GTC AAA AGT C-5′ and 3′-TGC AGG GCC CTA GCG
GCC GCT CAC GCA TAG TCA GGA ACA TCG TAT
GGG TAT TTA TAC ATT CTC AAG TCT A-5′. The
two amplicons were purified and then digested with NotI
and PshAI restriction enzymes. Ligation reactions were per-
formed with NotI-digested pCM185 (42). The sequence of
the insert and its junction regions was then verified byDNA
sequencing (Eurofins Scientific, Luxembourg). Restriction
enzymes were provided by New England Biolabs (Ipswich,
MA, USA).
Drop test assays
Logarithmically growing yeast cultures were diluted at 2 ×
106 cells/ml. A series of 10-fold dilutions were prepared,
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and 10 l drops were spotted on YEP or selective plates,
supplemented with the appropriate sugar and the indicated
drugs. Pictures were taken after incubation at 28◦C for 2–4
days.
Sensitivity assay
Exponentially growing cells were synchronized in the G1
phase by adding -factor (4g/ml) (Primm,Milano, Italy).
Upon appropriate dilutions, 100 CFU of each strain were
plated on YEPRG ± 25 mM HU. After 4 days of incuba-
tion, the number of grown colonies was counted and nor-
malized. The standard error of the mean (SEM) was calcu-
lated on three independent experiments.
SDS-PAGE and western blot
TCA protein extracts were prepared, and an equal amount
of each sample was separated by SDS-PAGE (44). West-
ern blottings were performed with anti-Rad53 (kind gift by
C. Santocanale), anti-HIS-tag (70796-3 Novagen, Merck,
Darmstadt, Germany) or anti-miniAID-tag (MBL Inter-
national, Woburn, MA, USA (43)) or anti-Pgk1 (22c5d8
Abcam, Cambridge, UK) antibodies, using standard tech-
niques.
FACS analysis
Cells were fixed in 70% ethanol and treated with RNase
A and proteinase K. DNA was stained with Sytox Green
(Thermo Fisher Scientific, Waltham, MA, USA), and cell
cycle distribution was estimated by cytofluorimetric analy-
sis with a FACScan (BD Biosciences, San Jose`, CA, USA).
Data were plotted using the FlowJo® Software.
Ribonucleotide incorporation assay
The assay was performed as described in details in (45).
Briefly, genomic DNA was isolated using Y-DER (Thermo
Fisher Scientific,Waltham,MassachusettsUSA) extraction
kit according tomanufacturer’s instruction and treatedwith
Escherichia coli RNase HII (NEB, Ipswich, Massachusetts
USA), which introduces nicks at every ribonucleotide-
containing site. The nicks were then used to radioactively
label the site with DNA Polymerase I (NEB, Ipswich, MA,
USA) in the presence of unlabeled dA/-dT/-dGTP and -
32P-dCTP (Perkin Elmer, Waltham, MA, USA). Labeled
genomic DNAwas separated by agarose gel electrophoresis
in the presence of ethidiumbromide, imaged underUV light
and quantified with ImageLab software (Bio-Rad). The gel
was successively dried, and the radioactive signal was de-
tected by autoradiography using a Typhoon FLA 7000 (GE
Healthcare Life Sciences, Marlborough, MA, USA) and
quantified with ImageQuant software (GE Healthcare Life
Sciences, Marlborough, MA, USA). The radioactive sig-
nal of each sample was normalized on total genomic DNA
measured by ethidium bromide staining. The ratio between
in-vitro RNHII-treated and the untreated sample was ex-
pressed as fold change respect to the control sample. The
mean of four different experiments ± SEM is reported in
the figure.
RESULTS
DNA polymerase  is responsible for HU-induced cell lethal-
ity in the absence of RNase H activities
Yeast cells lacking both RNase H activities (rnh1Δ
rnh201Δ) are sensitive to several genotoxic and replica-
tion stress-inducing agents, such as MMS, CPT, and HU
(7,46,47). In particular, following HU treatment, the Post
Replication Repair (PRR) pathway becomes essential for
cell survival, and TLS polymerase  is critical to help
replicative polymerases bypass the ribonucleotides persist-
ing in the template strand of genomic DNA (7). Unexpect-
edly, we found that the simultaneous loss of all yeast TLS
polymerases, Pol  , Pol  and Rev1 (rev3Δ rev7Δ rad30Δ
rev1Δ) almost completely suppresses the HU sensitivity
phenotype of rnh1Δ rnh201Δ cells (Figure 1A). By ana-
lyzing the individual contribution of each TLS polymerase,
we found that the suppression of HU sensitivity is almost
completely dependent upon the loss of DNA polymerase 
(encoded by RAD30 gene) (Figure 1A). Furthermore, Pol
 affects rnh1Δ rnh201Δ cell viability specifically following
HU treatment, but not upon treatment with other genotoxic
agents impacting on S phase, like MMS (Figure 1B).
Low doses of HU induce a Pol -dependent DNA damage
checkpoint activation and mitotic arrest in RNase H deficient
cells
We have previously shown that upon treatment with low
doses of HU, RNase H lacking cells exhibit DNA damage
checkpoint activation and cell cycle arrest at G2/M phase
(7). Given the involvement of Pol  in the HU sensitivity
of rnh1Δ rnh201Δ cells, we tested its contribution to such
checkpoint activation.
The phosphorylation state of the checkpoint effector ki-
nase Rad53 was used as a readout for DNA damage check-
point (DDC) activation, while cell cycle profiles were ana-
lyzed by flow cytometry (48,49). Cells were synchronized in
G1 phase with -factor, released in 25 mM HU, and col-
lected at the indicated time points. At low doses of HU,
wild type cells exhibit a mild and transient activation of the
DDC in S phase; the checkpoint response is then switched
off, and cell cycle progression continues (Figure 2A and B).
In rnh1Δ rnh201Δ cells, however, Rad53 phosphorylation
persists after S phase and cells cannot complete the cell cy-
cle and entry into the next G1 phase is delayed (Figure 2A
and B). Consistently with their reduced viability, a fraction
of these cells remains in G2/Mwith 2C DNA content (Fig-
ure 2A); no cell cycle defects or Rad53 phosphorylation are
observed in the absence of HU (Supplementary Figure S1).
Intriguingly, deletion of RAD30 rescues almost completely
all the HU-induced phenotypes observed in RNase H mu-
tants. Indeed, most rnh1Δ rnh201Δ rad30Δ cells dephos-
phorylate Rad53 and exhibit an almost wild type kinetics
of cell cycle progression (Figure 2A and B).
It is worth noting that even in the absence of RAD30
a small proportion of cells remain blocked in G2/M with
Rad53 phosphorylated, suggesting that other polymerases
may contribute to the HU-induced toxicity.
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Figure 1. Removal of Pol  rescues the HU sensitivity of cell lacking RNase H activities. 10-fold serial dilutions of the indicated strains were plated on (A)
YEPD and YEPD + 25 mM HU and (B) on YEPD, YEPD + 25 mM HU and YEPD + 0.01% MMS. Plates were incubated at 28◦C and pictures were
taken after 3 days. Results are representative of four biological replicates.
Pol  acts at HU-stressed replication forks
Hydroxyurea is known to induce replication forks stalling
and the formation of ssDNA gaps, which are filled in late S
phase mainly by TLS polymerases (50–52). Yeast Pol was
reported to be recruited to the proximity of replication ori-
gins during HU-induced stress (34,53). In human cells, Pol
 actively participates to CFSs replication, possibly by sub-
stituting Pol  (31–33), and forms nuclear foci upon hydrox-
yurea exposure (54). Thus, we asked whether the toxic activ-
ity of Pol occurs at the fork duringDNA replication under
low dNTPs conditions or post-replication, during gap refill-
ing in late S phase/G2.
In order to address this question, we exploited a yeast
strain lacking endogenous RAD30, where Pol  could be
conditionally overexpressed at different times following a
transient exposure to HU. We first tested whether an acute
exposure to high levels of HU had the same effect as the
chronic low dose HU treatment used so far. We exposed
-factor synchronized cells for two hours to 200 mM HU,
which was then washed out, rapidly restoring physiological
dNTPs level (55–57). Upon release in the cell cycle in the ab-
sence of HU, rnh1Δ rnh201Δ cells exhibited similar, albeit
milder, phenotypes as those reported following a chronic ex-
posure to 25 mM HU (compare Supplementary Figure S2
and Figure 2). Importantly, even though the drug was re-
moved from the medium when cells resumed cell cycle pro-
gression, the activation of theDDCand theG2/Mcell cycle
arrest in rnh1Δ rnh201Δ cells was still dependent on Pol 
(Supplementary Figure S2).
To determine when Pol  exerts its toxic activity, we syn-
chronized rnh1Δ rnh201Δ rad30Δ cultures, and we induced
RAD30 overexpression, before, immediately after or 30′ af-
ter the acute HU treatment. In the first case, cells were sub-
jected to nucleotide depletion in the presence of Pol . In
the other samples, cells experienced the HU-induced stress
in the absence of Pol , which was expressed only immedi-
ately or 30′ after HU removal. Protein levels were verified
by western blotting; cell cycle progression and DDC activa-
tion were monitored as previously described. Intriguingly,
we observed a strong accumulation of G2/M arrested cells
and Rad53 phosphorylation only when Pol was concomi-
tantly present with hydroxyurea during DNA replication
(Figure 3, before HU treatment). In contrast, when Pol 
was induced after the removal of HU, most cells did not ex-
hibit cell cycle progression defects or DDC activation (Fig-
ure 3, 0 min after HU release, 30 min after HU release).
These data indicate that Pol  exerts its toxic effect at repli-
cation forks when they are slowed down and challenged by
low dNTPs conditions.
Pol  toxicity is independent of ribonucleotides embedded in
the DNA replication template
Since Pol  activity becomes toxic only in the absence of
RNase H, it is essential to assess how the two are related
to each other. Lack of RNase H causes the genome-wide
accumulation of unprocessed ribonucleotides, which could
stimulate a Pol  activity that becomes toxic when dNTP
pools have been depleted. On the other hand, Pol  may
be recruited at the HU-stressed replication forks generat-
ing a product that becomes toxic in the absence of RNase
H. In the first scenario, Pol would be toxic in the absence
of RNase H due to the presence of rNMPs in the template
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Figure 2. Pol  is responsible for the DNA damage checkpoint activation and G2/M arrest of RNase H deficient cells in low doses of HU. Exponentially
growing cells were synchronized in G1 phase by -factor addition (4 g/ml) and released in 25 mMHU; -factor (10 g/ml) was re-added to the medium
90 min after the release to block cells in the next G1 phase. (A) Cell cycle progression was followed by flow cytometry (FACS) measuring DNA content (1C,
2C) at the indicated time points. (B) Rad53 phosphorylation was analyzed by western blotting of total cell extracts with anti-Rad53 antibodies. Results are
representative of four biological replicates.
strand. In the second case, the inability to process ribonu-
cleotides would be lethal only after Pol  action. To distin-
guish between these two hypotheses, we evaluated the ef-
fects of unprocessed rNMPs within a single cell cycle. We
produced a heterologous conditional system, where RNase
H2 can be inactivated at different times in a synchronous
culture. A yeast strain was generated where we expressed E.
coli rnhB gene fused to theAID-degron, so that the chimeric
protein is degraded following the addition of auxin (IAA)
(42,43). The fusion was cloned under the TetOFF promoter
so that its expression can be switched off by addition of
doxycycline (DOXY). The RNase H2 activity provided by
the RnhB-AID fusion protein complemented the simulta-
neous loss of RNase H1 and H2 in yeast cells, suppressing
almost completely the HU sensitivity and the accumulation
of ribonucleotides incorporated in genomic DNA (Supple-
mentary Figure S3). Moreover, expression of the rnhB-AID
construct did not alter cell cycle progression of an otherwise
wild type strain (Supplementary Figure S4).
rnh1Δ rnh201Δ cells carrying the conditional rnhB-AID
construct were grown in the presence of the RnhB (ON), al-
lowing efficient removal of pre-existing ribonucleotides, and
arrested with -factor. RnhB was then turned off (OFF)
in -factor, before the release in 25 mM HU impeding the
removal of newly incorporated ribonucleotides. Cells were
collected at different time points; cell cycle progression was
monitored by FACS analysis (Figure 4A), andDDC activa-
tion was evaluated by western blotting (Figure 4B). In the
presence of RnhB activity, despite being exposed to a low
dose of HU, strains mutated in RNH1 and RNH201 pro-
gressed throughout the cell cycle and normally reached the
nextG1 phase, similarly towild type cells (Figure 4A, panels
1, 3, 6). In these conditions, Rad53 hyperphosphorylation
was almost completely absent (Figure 4B, lanes 7, 9, 11).
These results further confirm that RnhB-AID efficiently
complements the absence of yeast endogenous RNaseH ac-
tivities.WhenRnhBwas turned off before the release inHU,
rnh1Δ rnh201Δ cells experienced the first round of DNA
replication in the presence of hydroxyurea and in the ab-
sence of RNase H activities (Figure 4A, lanes 4 and 7). In
these conditions, contrary to what observed when RnhB
was expressed, cells arrested atG2/Mwithin the first cell cy-
cle (Figure 4A, panel 4) with hyperphosphorylated Rad53
(Figure 4B, lane 10), with a phenotype similar to that of
rnh1Δ rnh201Δ cells carrying the empty plasmid (Figure
4A, panel 2 and Figure 4B, lane 8). Moreover, deletion of
RAD30 suppressed both the cell cycle arrest and the DDC
activation (Figure 4A, panel 7 and Figure 4B, lane 12).
These findings suggest that when Pol  acts at replication
forks in low dNTPs, it poses a lethal threat to cells if RNase
H activity is missing. This argues against the involvement in
the toxic effect of Pol  of pre-existing rNMPs in the tem-
plate strand.
Pol  toxicity is exerted via its catalytic activity, and it is en-
hanced by a steric gate mutation that increases rNTPs incor-
poration
To characterize themechanism underlying Pol  toxicity, we
investigated the involvement of its catalytic activity. HIS-
tagged wild type (RAD30), catalytic-dead (rad30-D155A-
E156A) alleles or a steric gate mutant with enhanced ri-
bonucleotide incorporation activity (rad30-F35A) (38,58)
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Figure 3. Pol  exerts its toxic activity at HU-stressed DNA replication forks. Cells were grown in SC-URA Raffinose 2%, arrested with -factor (4
g/ml) and released from the G1 block by transferring them in SC-URA Raffinose 2% with 200 mMHU for 2 h. HU was then washed out and cells were
transferred to fresh medium to allow completion of the cell cycle. -factor (10 g/ml) was re-added 90 min after HU wash out to block cells in the next G1
phase. Media were supplemented with Galactose 2% to induce RAD30 expression, when indicated (red). (A) Cell cycle progression was followed by flow
cytometry (FACS) measuring DNA content (1C, 2C) at the indicated time points. (B) Rad53 phosphorylation and Rad30-6xHis expression were analyzed
by western blotting of total cell extracts using appropriate antibodies. Results are representative of three biological replicates.
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Figure 4. Pol  generates toxic intermediates at stressed replication forks in HU. Exponentially growing cells were synchronized in SC-TRP glucose 2% by
-factor addition (4 g/ml) and released in YEPD + 25 mM HU. -factor (10 g/ml) was re-added 90 min after the release. RnhB was expressed (RnhB
ON, in green) and was depleted as needed by addition of 10 g/ml Doxycycline (DOXY) and 0.5 mM Auxin (IAA) (RnhB OFF, in gray). All the strains
host the OsTIR1 gene integrated at the URA3 locus. (A) Cell cycle progression was followed by flow cytometry (FACS) measuring DNA content (1C, 2C)
at the indicated time points. (B) Rad53 phosphorylation, RnhB-AID and the Pgk1 loading control were analyzed by western blotting of total cell extracts
using appropriate antibodies. Results are representative of three biological replicates.
were overexpressed in yeast cells under the control of the
GAL1/10 promoter. Overexpression was necessary because
the steric gate mutation although increasing rNTPs incor-
poration, strongly reduces the catalytic activity of the en-
zyme. Indeed, a rad30-F35A mutant expressed at the en-
dogenous level is catalytically deficient and UV sensitive,
while the UV sensitivity is suppressed when overexpressed,
likely because enough Pol catalytic is present (Supplemen-
tary Figure S5A and B). Cell viability in 25 mM HU was
measured and it is reported in Figure 5A. Overexpression
of either wild type or mutant forms of Pol  was achieved
at similar levels (Figure 5B) and did not noticeably affect
the viability of RNase H wild type cells both in untreated
or HU-treated conditions (Figure 5A, grey bars, and Sup-
plementary Figure S5C). In cells lacking RNase H, on the
other hand, overexpression of wild type Pol  exacerbated
the sensitivity to HU, linking the extent of the toxic activity
to the level of Pol  in cells (Figure 5A, black bars). Con-
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Figure 5. Pol  toxicity depends on its catalytic activity and it is exacerbated if its ribonucleotide-incorporation activity is increased. (A) Cells were grown
in SC-URA Raffinose 2% and arrested with -factor. Cultures were then appropriately diluted and plated on SC–URA supplemented with Galactose 2%
and Raffinose 2%, either with or without 25 mM HU. Colonies were counted from at least three plates after 4 days at 28◦C. Histogram bars represent the
ratio between colonies counted on plates with and without hydroxyurea. Error bars represent the standard error of the mean (SEM), calculated on three
independent experiments. (B) Overexpression levels of wild type and mutant versions of Rad30 were analyzed by western blot with anti-HIS antibodies 4
h after Galactose induction; equal loading was verified by Ponceau S staining.
versely, overexpression of the catalytic-dead mutant (rad30-
D155A-E156A) suppressed the HU-induced cell lethality
restoring viability to levels comparable to those observed
in RNase H proficient cells, implying that Pol  catalytic
activity is responsible for the HU sensitivity. This was con-
firmed by the steric gate mutant rad30-F35A, which con-
fers enhanced ribonucleotide incorporation activity (37,38)
and caused a drastic increase in HU sensitivity to rnh1Δ
rnh201Δ cells, suggesting that the incorporation of ribonu-
cleotides mediated by Pol  is the cause of cell lethality (Fig-
ure 5A, black bars).
To examine whether unprocessed genomic ribonu-
cleotides were responsible for the HU-induced lethality, we
analyzed the HU sensitivity imparted by individual RNH1
(RNase H1) and RNH201 (RNase H2) deletions, by an
RNase H2 catalytic-dead mutant (rnh201-D39A) and by
a separation of functions mutant rnh201-RED (rnh201-
P45D-Y219A), which has been reported to be able to pro-
cess multiple consecutive ribonucleotides, while being im-
paired in the removal of single rNMPs (40) (Figure 6A).
The same mutations were then combined with the deletion
of RAD30 to gain an insight into the type of toxic product
generated by Pol  (Figure 6B).
The results reveal that HU becomes lethal only when
cells cannot process consecutive ribonucleotides (rnh1Δ
rnh201Δ or rnh1Δ rnh201-D39A) but not if consecutive ri-
bonucleotides can be processed by RNase H1 (rnh201Δ) or
if the ability of RNase H2 to act on multiple rNMPs is pre-
served (rnh1Δ rnh201-RED). Intriguingly, the data shown
in Figure 6B also shows that Pol  is toxic only if mul-
tiple ribonucleotides cannot be processed, suggesting that
when the dNTP pools are decreased Pol  activity may pro-
mote the incorporation of stretches of ribonucleotides in the
genome.
DISCUSSION
Ribonucleotides are massively incorporated during DNA
replication by DNA polymerases, and, if not repaired, they
cause genome instability. Depletion of the dNTP pools by
hydroxyurea inhibits replicative DNA synthesis. Interest-
ingly, exposure of rnh1Δ rnh201Δ cells to even low lev-
els of HU leads to DNA damage checkpoint activation
and G2/M arrest. TLS DNA polymerase  is well known
for its roles in lesion bypass for the effective completion
of DNA synthesis, following exposure to DNA damaging
agents (23,24).
We describe a novel involvement of Pol  during genome
duplication under replication stress conditions. In partic-
ular, we propose that, when canonical DNA polymerases
are challenged by deoxyribonucleotide depletion, Pol 
facilitates replication fork progression and chromosomal
replication favoring the inclusion of consecutive ribonu-
cleotides in newly synthesized genomic DNA. Pol  is suit-
able for this function thanks to its ability to extend DNA or
RNA primers with ribonucleotides (37,38), unlike replica-
tive DNA polymerases, which exhibit lower incorporation
capability and are blocked by dNTPs shortage (2,3). Even
though this function may be relevant to complete DNA
replication and tolerate temporary decreases in the dNTP
pools, it presents a potentially lethal challenge when RNase
H activities are absent, and chromosome embedded ribonu-
cleotides are excessively accumulated (Figure 7). The ge-
nomic sites bound by Pol  in HU-treated cells have been
previously mapped and some of them correspond to ARSs
(34) that are actively replicated in cells exposed to 200 mM
HU (34,53). Moreover, human Pol  is required for S phase
progression in hydroxyurea, and its activity induces apop-
totic cell death (36,54).
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Figure 6. HU sensitivity is due to the failure to process multiple consecutive ribonucleotides. 10-fold serial dilutions of the indicated strains were plated
on YEPD and YEPD + 25 mM HU and incubated at 28◦C. Pictures were taken after 2 days of incubation. Results are representative of two biological
replicates. The D39A mutation inactivates the catalytic function of RNase H2 while the separation of function mutant rnh201-RED allows the removal of
stretches of rNMPs but is impaired in the removal of single rNMPs.
In this work we show that:
a) When cellular dNTP pools are depleted by exposure to
low doses of HU, Pol  catalytic activity promotes the
formation of some structures that become toxic only if
RNase H activities are lost, while no effect is detected in
cells expressing RNase H functions. This strongly sug-
gests a role for ribonucleotides in the Pol -dependent
HU-induced lethality.
b) Such toxic products are generated when Pol  is active at
replication forks stressed by dNTPs depletion, while no
problem arises if Pol  acts later in S phase, once dNTP
pools have been replenished.
c) The formation of the toxic products by Pol  does not
depend upon residual rNMPs in the template strand,
but it involves ribonucleotides incorporated during the S
phase with low dNTP pools, and it elicits a DNA dam-
age checkpoint and G2/M arrest within the same cell
cycle.
d) The sensitivity to HU, and thus the formation of the
toxic products, is greatly enhanced if cells express a Pol
 variant with enhanced rNTPs incorporation ability.
Moreover, the HU-induced lethality depends upon the
inability in the processing of multiple consecutive ri-
bonucleotides.
Physical detection of multiple rNMPs embedded in ge-
nomic DNA has proven to be very hard to tackle with
the available technology; no groups to our knowledge were
able to address this problem yet. Even if we cannot directly
measure the presence of Pol -dependent multiple ribonu-
cleotides, the data summarized above very strongly support
the hypothesis that the phenotypes reported in this work
are related to RNA stretches embedded in genomic DNA,
which are accumulated only when Pol  is active and the
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Figure 7. Proposed model of Pol  function during hydroxyurea-mediated fork stalling. Replication forks are stalled by dNTP pools depletion caused
by HU, allowing Pol  recruitment. Pol  activity promotes RNA:DNA hybrids formation by either direct incorporation of ribonucleotides in the newly
synthesized strand or incorrect Okazaki fragments maturation or R-loops stabilization. These hybrids are later processed by RNase H activities, allowing
completion of the cell cycle. In the absence of RNase H, RNA:DNA hybrids are not removed from the genome and lead to DNA damage checkpoint
activation, cell cycle arrest and ultimately cell death.
dNTP pools are depleted. Such RNA stretches may arise
from the direct incorporation of rNTPs by Pol , from
a Pol -dependent stabilization of R-loops or impairment
of Okazaki fragments processing, consistently with recent
evidence showing that Pol  could take part in the repli-
cation of the lagging strand (59). Remarkably, following
replication with low dNTP pools and active Pol , if ri-
bonucleotides cannot be processed cells die because they
cannot divide (Figure 7). Careful kinetic analyses reveal
that, in these conditions, the DDC is switched off after S
phase and re-activated when cells reach 2C DNA content
in G2/M. Taken together, these observations may corre-
late RNA:DNA hybrids with chromosome segregation. We
propose thatRNA:DNAhybridsmay compromise chromo-
somes structure (17–19,60) generating problems that are de-
tected in G2/M and trigger the DDC. Such hybrids may
also lead to mutagenic repair mechanisms, such as the one
dependent on Top1, leading to deletions and chromosome
breaks (15,16). We can also envision that the alteration of
chromosome structure due to newly incorporated ribonu-
cleotides may affect particular regions, e.g. centromeres, es-
sential for proper cell division. This hypothesis is supported
by the observation that deletion of the Spindle Assembly
Checkpoint factorMAD2 partially rescues theHU sensitiv-
ity, cell cycle arrest of cells lacking RNase H and persistent
DNA damage checkpoint activation (Supplementary Fig-
ure S6).
As mentioned above, such scenario may be conserved in
higher eukaryotes as well. This mechanism resembles the
one reported in human cells for Chromosome Fragile Sites
(CFSs) replication. CFSs are peculiar sequences that as-
sume non-B DNA structures that block replication forks
(61,62). Here, Pol  substitutes Pol  and carries on DNA
synthesis, avoiding the formation of breaks and preventing
under-replicated DNA from entering mitosis (30–33). As
in hydroxyurea, Pol  may act when replication forks are
stalled.
In conclusion, this study unravels a novel role of TLS
polymerase  and provides evidence of its contribution to
the preservation of genome integrity. In the future, it will be
interesting to investigate how Pol  can participate to repair
synthesis in environments where dNTP pools are physiolog-
ically low, such as in neuronal cells.
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